MPH Health Care AG (DE:93M1)
XETRA:93M1
Top Page
MPH Health Care AG
(XETRA:93M1)
Select Model
Select Model
Rating:70Outperform
Price Target:
€25.00
▲(13.12% Upside)
Action:UpgradedDate:12/13/25
The stock score is primarily driven by strong technical indicators and solid financial performance, despite valuation concerns due to a negative P/E ratio. The attractive dividend yield partially offsets these valuation issues. The absence of earnings call data and corporate events means these factors did not influence the score.
Positive Factors
Strong Balance Sheet
A robust balance sheet with high equity and low leverage provides durable financial flexibility: it supports funding of portfolio transactions, cushions downturns, and reduces refinancing risk, enabling sustained capital allocation to strategic investments and distributions.
Negative Factors
Cash Flow Volatility
Volatile operating and free cash flows create uncertainty in funding ongoing operations, dividend sustainability, and the ability to support portfolio companies. This volatility can force reliance on asset sales or external financing, adding execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Balance Sheet
A robust balance sheet with high equity and low leverage provides durable financial flexibility: it supports funding of portfolio transactions, cushions downturns, and reduces refinancing risk, enabling sustained capital allocation to strategic investments and distributions.
Read all positive factors
MPH Health Care AG (93M1) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€77.71M
Dividend Yield5.31%
Average Volume (3M)1.46K
Price to Earnings (P/E)―
Beta (1Y)0.21
Revenue Growth180.19%
EPS Growth-196.45%
CountryDE
Employees2
SectorFinancial
Sector Strength70
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,281,384
10 Day Avg. Volume2,127
30 Day Avg. Volume1,460
Financial Highlights & Ratios
PEG Ratio0.36
Price to Book (P/B)0.35
Price to Sales (P/S)15.83
P/FCF Ratio53.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.9
Revenue Forecast (FY)€24.74M
MPH Health Care AG Business Overview & Revenue Model
Company Description
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; ...
How the Company Makes Money
MPH Health Care AG generates revenue through multiple streams, primarily from the sale of its medical devices and health management software. The company partners with hospitals, clinics, and healthcare providers to supply its products, often ente...
MPH Health Care AG Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
85
Very Positive
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -72.59M | 6.11M | 7.24M | 6.85M | 4.36M | -9.02M |
| Gross Profit | -72.59M | 6.11M | 125.94M | 6.80M | 4.01M | -9.45M |
| EBITDA | -37.87M | 33.32M | 30.36M | 29.68M | -9.05M | -71.00M |
| Net Income | -115.23M | 32.04M | 29.54M | 29.11M | -8.96M | -70.38M |
Balance Sheet | ||||||
| Total Assets | 218.84M | 291.06M | 266.35M | 236.99M | 198.00M | 210.71M |
| Cash, Cash Equivalents and Short-Term Investments | 2.65M | 1.20M | 5.10M | 3.82M | 4.44M | 4.23M |
| Total Debt | 11.72M | 10.56M | 13.05M | 12.99M | 4.05M | 7.62M |
| Total Liabilities | 13.72M | 13.19M | 15.39M | 15.57M | 5.69M | 9.45M |
| Stockholders Equity | 205.12M | 277.87M | 250.97M | 221.42M | 192.31M | 201.26M |
Cash Flow | ||||||
| Free Cash Flow | 1.02M | 1.83M | -2.02M | -170.41K | -1.28M | -3.36M |
| Operating Cash Flow | 3.59M | 1.83M | -2.02M | -164.79K | -1.28M | -3.36M |
| Investing Cash Flow | 4.10M | 3.40M | 5.40M | -8.96M | 6.37M | 12.83M |
| Financing Cash Flow | -6.85M | -7.70M | 7.74M | -3.02M | -3.61M | -10.90M |
MPH Health Care AG Technical Analysis
Negative
22.10
Price Trends
21.67
Negative
21.73
Negative
19.87
Negative
Market Momentum
-1.05
Positive
27.70
Positive
27.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:93M1, the sentiment is Negative. The current price of 22.1 is above the 20-day moving average (MA) of 19.54, above the 50-day MA of 21.67, and above the 200-day MA of 19.87, indicating a bearish trend. The MACD of -1.05 indicates Positive momentum. The RSI at 27.70 is Positive, neither overbought nor oversold. The STOCH value of 27.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:93M1.
MPH Health Care AG Peers Comparison
UnderperformOutperform
Sector (68)
DE:93M1
MPH Health Care AG
18.15
-3.26
-15.23%
DE:LIK
Limes Schlosskliniken AG
476.00
190.00
66.43%
DE:HAEK
HAEMATO AG
12.00
1.39
13.10%
DE:AJ91
DocCheck AG
11.60
2.13
22.49%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.